Ipsilesional Mu Rhythm Desynchronization and Changes in Motor Behavior Following Post Stroke BCI Intervention for Motor Rehabilitation.
Alexander B Remsik, Leroy Williams, Klevest Gjini...
https://pubmed.ncbi.nlm.nih.gov/30899211/Actively Recruiting
Led by University of Wisconsin, Madison · Updated on 2026-05-15
288
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating whether combining two non-invasive brain stimulation methodsmuscle stimulation of the arm using functional electrical stimulation FES and neurostimulation through the tonguecan improve recovery after stroke. This study focuses on adults who have experienced a stroke and have upper extremity motor impairments, aiming to measure changes in motor function and brain plasticity using behavioral tests and functional MRI scans. Participants are divided into several groups including stroke patients with upper extremity impairments receiving EEG-guided brain-computer interface BCI training combined with muscle and tongue stimulation, stroke patients receiving traditional rehabilitation before starting BCI-FES-tongue therapy, stroke patients receiving standard FES therapy only, healthy controls, and people with stroke risk factors. The study involves training sessions with the EEG-BCI system, muscle and tongue stimulation, and the use of the recoveriX system, which provides real-time visual and tactile feedback paired with imagined hand movements. The intervention periods vary, with some groups receiving delayed therapy and others immediate BCI therapy. Participants will undergo multiple assessments including behavioral tests of upper extremity function, EEG recordings, and functional MRI scans at the start and after about four months of therapy. The researchers will monitor changes in arm function using the Action Research Arm Test and observe brain activity changes through EEG and fMRI. The study includes up to six BCI training sessions and regular evaluations over approximately 10 weeks, with some groups receiving additional follow-up MRI and behavioral testing. Safety screening excludes those with allergies to electrode materials or contraindications for MRI, and pregnant women are not eligible.
CONDITIONS
A Closed Loop Neural Activity Triggered Stroke Rehabilitation Device
R
Radiology Studies
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Wisconsin, Madison
Lead Sponsor
American Heart Association
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Immediate BCI‑FES | Delayed BCI‑FES | RecoveriX BCI‑device therapy | Active Control Groups | Standard High‑Intensity UL Rehabilitation |
|---|---|---|---|---|---|
| What it is | An investigational closed‑loop brain‑computer interface paired with functional electrical stimulation for upper limb rehabilitation delivered immediately after randomization | Same closed‑loop BCI‑FES system delivered after a delay period | BCI‑driven rehabilitation using the RecoveriX brain‑driven system | Active control groups including stroke patients without upper extremity deficits and healthy controls | High‑intensity, task‑specific upper limb rehabilitation as currently recommended in stroke recovery guidelines |
| Role in the trial | One of the active investigational intervention arms | Active comparator delaying intervention to assess temporal effects | Alternative investigational device arm employing RecoveriX BCI system | Control groups with stroke patients without impairment and healthy controls serving as active comparators | Represents conventional rehabilitation practices patients would typically receive outside the trial |
| Primary use | To restore upper limb motor function via closed‑loop BCI‑triggered muscle stimulation immediately | Same purpose as immediate arm but with delayed initiation | To engage motor recovery using the RecoveriX brain‑driven rehabilitation system | To serve as comparative controls without BCI‑triggered interventions | To improve upper limb motor function through intensive task‑specific rehabilitation |
| How it is given or performed | BCI system detects neural activity and triggers functional electrical stimulation immediately | Same BCI‑FES method, but delivered after a defined delay period | Utilizes RecoveriX BCI system pairing brain signals with motor actions for rehabilitation | Participants undergo assessments without BCI‑triggered therapy | Conventional rehabilitation involves early, intensive, repetitive upper limb task practice |
| Evidence status | Early trials report improvement in motor outcomes such as arm movement and EEG changes | Effect of delayed delivery yet to be determined | Preliminary data suggest brain‑computer interface can influence motor activity patterns | Not intended to produce motor recovery, used for baseline comparison | Supported by strong evidence for improving upper limb motor recovery through high‑intensity, task‑specific therapy |
| Important risks | Not yet established; investigational device safety data not publicly reported | Not yet established | Not yet established | Not applicable | Well‑understood safety profile in clinical practice |
| Important limitations | Early phase data; efficacy and safety still being investigated | Unknown whether delay in starting therapy affects outcomes | Limited preliminary outcomes; broader clinical relevance not yet defined | Control groups do not receive rehab intervention, so not reflective of standard care | General recommendation; may lack personalization provided by BCI‑based interventions |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 10 weeks depending on group assignment
Participants receive training on the EEG-BCI system and complete baseline behavioral testing and MRI scans before starting therapy.
4 training sessions and 2 behavioral testing sessions with MRI scans before therapy
Duration - Approximately 8 to 10 weeks or longer depending on group assignment
Participants in the experimental groups receive EEG-BCI guided functional muscle stimulation therapy, including closed-loop brain-computer interface training paired with functional electrical stimulation and tongue neurostimulation.
Multiple therapy sessions including muscle and tongue stimulation; exact number varies by group
Duration - Duration consistent with treatment period
A subgroup of participants receive brain-driven rehabilitation using the recoveriX system, combining EEG-based feedback with bilateral functional electrical stimulation.
Multiple therapy sessions with bilateral arm stimulation
Duration - Throughout the study duration, particularly at baseline and 4 months
Participants undergo behavioral assessments and MRI scans to measure stroke recovery and brain plasticity before and after treatment.
At least 2 behavioral testing sessions and MRI scans
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Alexander B Remsik, Leroy Williams, Klevest Gjini...
https://pubmed.ncbi.nlm.nih.gov/30899211/Alexander B Remsik, Keith Dodd, Leroy Williams...
https://pubmed.ncbi.nlm.nih.gov/30467461/Brittany M Young, Zack Nigogosyan, Léo M Walton...
https://pubmed.ncbi.nlm.nih.gov/26157378/Jie Song, Veena A Nair, Brittany M Young...
https://pubmed.ncbi.nlm.nih.gov/25964753/Jie Song, Brittany M Young, Zack Nigogosyan...
https://pubmed.ncbi.nlm.nih.gov/25120466/Brittany M Young, Julie M Stamm, Jie Song...
https://pubmed.ncbi.nlm.nih.gov/27695404/Brittany M Young, Zack Nigogosyan, Veena A Nair...
https://pubmed.ncbi.nlm.nih.gov/25009491/University of Wisconsin, Madison
Lead Sponsor
American Heart Association
Collaborating Sponsor